These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8818545)

  • 1. Long-term protection against the effects of tumour necrosis factor by controlled delivery of the soluble p55 TNF receptor.
    Eliaz R; Wallach D; Kost J
    Cytokine; 1996 Jun; 8(6):482-7. PubMed ID: 8818545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.
    Peschon JJ; Torrance DS; Stocking KL; Glaccum MB; Otten C; Willis CR; Charrier K; Morrissey PJ; Ware CB; Mohler KM
    J Immunol; 1998 Jan; 160(2):943-52. PubMed ID: 9551933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1.
    Amar S; Van Dyke TE; Eugster HP; Schultze N; Koebel P; Bluethmann H
    J Inflamm; 1995-1996; 47(4):180-9. PubMed ID: 9144075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor and its p55 and p75 receptors are not required for axonal lesion-induced microgliosis in mouse fascia dentata.
    Fenger C; Drojdahl N; Wirenfeldt M; Sylvest L; Jorgensen OS; Meldgaard M; Lambertsen KL; Finsen B
    Glia; 2006 Nov; 54(6):591-605. PubMed ID: 16927297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
    Rasmussen CA; Pace JL; Banerjee S; Phillips TA; Hunt JS
    Placenta; 1999; 20(2-3):213-22. PubMed ID: 10195744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble tumour necrosis factor receptor release after anti-CD3 monoclonal antibody treatment in mice is independent of tumour necrosis factor-alpha release.
    Vossen AC; Tibbe GJ; Buurman WA; Benner R; Savelkoul HF
    Eur Cytokine Netw; 1996 Dec; 7(4):751-5. PubMed ID: 9010677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha (TNF) regulates the expression of ICAM-1 predominantly through TNF receptor 1 after chronic constriction injury of mouse sciatic nerve.
    Schäfers M; Schmidt C; Vogel C; Toyka KV; Sommer C
    Acta Neuropathol; 2002 Aug; 104(2):197-205. PubMed ID: 12111363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation.
    Zhuang L; Wang B; Shinder GA; Shivji GM; Mak TW; Sauder DN
    J Immunol; 1999 Feb; 162(3):1440-7. PubMed ID: 9973400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of prostaglandin E2 and collagenase is inhibited by the recombinant soluble tumour necrosis factor receptor p55-human gamma 3 fusion protein at concentrations a hundred-fold lower than those decreasing T cell activation.
    Nicod LP; Isler P; Chicheportiche R; Songeon F; Dayer JM
    Eur Cytokine Netw; 1996 Dec; 7(4):757-63. PubMed ID: 9010678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
    Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
    J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia.
    Catalano MG; Fortunati N; Arena K; Costelli P; Aragno M; Danni O; Boccuzzi G
    Int J Oncol; 2003 Aug; 23(2):429-36. PubMed ID: 12851692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel TNF alpha ligand-receptor binding assay for screening NATCHEM Libraries.
    MacAllan D; Sohal J; Walker C; Hill D; Moore M
    J Recept Signal Transduct Res; 1997; 17(1-3):521-9. PubMed ID: 9029512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of recombinant tumor necrosis factor determines its lethality in mice.
    Ameloot P; Takahashi N; Everaerdt B; Hostens J; Eugster HP; Fiers W; Brouckaert P
    Eur J Immunol; 2002 Oct; 32(10):2759-65. PubMed ID: 12355427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
    Modzelewski B
    Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha.
    Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM
    Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabies virus ocular disease: T-cell-dependent protection is under the control of signaling by the p55 tumor necrosis factor alpha receptor, p55TNFR.
    Camelo S; Castellanos J; Lafage M; Lafon M
    J Virol; 2001 Apr; 75(7):3427-34. PubMed ID: 11238868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.
    Aderka D; Sorkine P; Abu-Abid S; Lev D; Setton A; Cope AP; Wallach D; Klausner J
    J Clin Invest; 1998 Feb; 101(3):650-9. PubMed ID: 9449699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor.
    Gary DS; Bruce-Keller AJ; Kindy MS; Mattson MP
    J Cereb Blood Flow Metab; 1998 Dec; 18(12):1283-7. PubMed ID: 9850139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.